Patent · US Active

Benzotriazine inhibitors of kinases

US7456176B2 · kind B2 · utility

4Cited by
57References
34Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 7, 2005
Grant dateNov 25, 2008
Priority date
Expiry dateJul 3, 2026

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D413/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides benzotriazine compounds having formula (I). The benzotriazine compounds of the invention are capable of inhibiting kinases, such members of the Src kinase family, and various other specific receptor and non-receptor kinases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.